Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson: Recalled drugs delayed again

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney) -- Johnson & Johnson said Tuesday that consumers may have to wait until the end of the year before drugstore shelves start to fill up again with its recalled children's Tylenol, Motrin and Bendryl.

During a meeting with analysts and investors, company executives said J&J (JNJ, Fortune 500) had shipped a small amount - about 4 million bottles of Children's Tylenol - to stores last quarter.

J&J had hoped to restock retailers with all the recalled children's medicines by the middle of 2011. However, executives said Tuesday that retailers wouldn't receive adequate supplies of those medicines until the later half of the year, "slightly later than expected."

J&J halted production at its Ft. Washington Pa. plant in May, where its pediatric pain and cold drugs are manufactured, following a recall of millions of those medicines for quality concerns. Facing shortages, It shifted production to one of its Canadian plants hoping to normalize supplies.

Also on Tuesday, Johnson & Johnson (JNJ, Fortune 500) reported fourth-quarter profits that met analysts' estimates, despite softer-than-expected sales.

The company said sales in the quarter were significantly hurt by its numerous recalls of Tylenol, Motrin and Benadryl products and the suspension of manufacturing at the the Fort Washington plant.

Those recalls, followed by an absence of those medicine in stores, significantly hurt the company's over-the-counter drugs business. Its OTC sales tumbled 53% in the fourth quarter, costing the company $300 million in lost sales in the period as $900 million in lost sales for the year.

Johnson & Johnson also issued a full-year 2011 profit outlook of between $4.80 to $4.90 a share, also weaker than analysts' estimates.

Analysts, on average, had expected the company to earn $4.97 a share on average for the year, according to Thomson Reuters.  To top of page

Index Last Change % Change
Dow 16,374.76 23.38 0.14%
Nasdaq 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
Treasuries 2.17 -0.02 -1.14%
Data as of 12:53am ET
Company Price Change % Change
Bank of America Corp... 15.94 0.09 0.57%
Apple Inc 110.37 -1.97 -1.75%
Freeport-McMoRan Inc... 10.13 0.23 2.32%
Intel Corp 29.08 0.48 1.68%
Frontier Communicati... 5.52 0.31 5.95%
Data as of Sep 3
Sponsors

Sections

Americans are transforming how they eat -- paying more attention to the origins of their food and how it's made. And Kimbal Musk is at the forefront of a movement that is accelerating the rate of change. More

The Labor Department releases its August jobs report on Friday, and it will have big implications for the Federal Reserve. More

The BauBax travel jacket, with 15 built-in features, needed $20,000 on Kickstarter, but got $9 million. More

Pimco's famous fund once managed by star manager Bill Gross has less than $100 billion in management for the first time since 2007. More